lansoprazole has been researched along with Sclerosis, Systemic in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abignano, G | 1 |
| Scott, N | 1 |
| Wollheim, FA | 1 |
| Emery, P | 1 |
| Buch, MH | 1 |
| Del Galdo, F | 1 |
| Chatterjee, S | 1 |
2 other studies available for lansoprazole and Sclerosis, Systemic
| Article | Year |
|---|---|
Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.
Topics: Aged; Biopsy, Needle; Budesonide; Colitis, Collagenous; Colonoscopy; Drug Administration Schedule; F | 2014 |
Watermelon stomach.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Follow-Up Studies; Gastric Antral Vascular Ectasia; G | 2008 |